Molecular Characterization Initiative (MCI) Update: Pediatric Soft Tissue Sarcomas

If you’re interested in learning how NCI’s Molecular Characterization Initiative (MCI) is making a difference for patients with soft tissue sarcoma, don’t miss this upcoming Childhood Cancer Data Initiative (CCDI) webinar!

Join NCI’s Dr. Jack Shern as he discusses MCI’s impact on pediatric soft tissue sarcoma patients. Together, you will explore:

• MCI strategy—Get an inside look at their strategic approach in adding new cohorts and advancements in assay technologies and data access.
• MCI progress—Discover the progress they’ve made by using the publicly shared genomic and clinical data specifically for soft tissue sarcoma patients.
• Clinical impact—Learn how MCI’s molecular profiling is enhancing treatment options and transforming patient care.
• Future innovations—See how MCI data is not just enriching current clinical trials but also setting the stage for future innovative cancer research.

If you are an individual with a disability who needs reasonable accommodations to participate in this event, please email CCDIevents@mail.nih.gov as soon as possible.

This webinar is part of the CCDI webinar series, which highlights how to use CCDI’s web applications, platforms, and data, and gives attendees the opportunity to learn how to use available resources. Webinars will be recorded and made available for viewing post-event.